ECSP14026022A - NITROGENATED HETEROCYCLIC COMPOUND - Google Patents

NITROGENATED HETEROCYCLIC COMPOUND

Info

Publication number
ECSP14026022A
ECSP14026022A ECIEPI201426022A ECPI201426022A ECSP14026022A EC SP14026022 A ECSP14026022 A EC SP14026022A EC IEPI201426022 A ECIEPI201426022 A EC IEPI201426022A EC PI201426022 A ECPI201426022 A EC PI201426022A EC SP14026022 A ECSP14026022 A EC SP14026022A
Authority
EC
Ecuador
Prior art keywords
heterocyclic compound
nitrogenated heterocyclic
nitrogenated
schizophrenia
prophylaxis
Prior art date
Application number
ECIEPI201426022A
Other languages
Spanish (es)
Inventor
Masanori Kawasaki
Satoshi Mikami
Shigekazu Sasaki
Shinji Nakamura
Izumi Nomura
Tomoko Ashizawa
Takahiko Taniguchi
Original Assignee
Eh Europe Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eh Europe Gmbh filed Critical Eh Europe Gmbh
Publication of ECSP14026022A publication Critical patent/ECSP14026022A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un compuesto heterocíclico que contiene nitrógeno que tiene acción inhibidora selectiva de la PDE2A, el cual es útil como agente para la profilaxis o tratamiento de esquizofrenia, la enfermedad de Alzheimer y similar.The present invention relates to a nitrogen-containing heterocyclic compound having selective PDE2A inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like.

ECIEPI201426022A 2012-04-25 2014-11-07 NITROGENATED HETEROCYCLIC COMPOUND ECSP14026022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012100374 2012-04-25

Publications (1)

Publication Number Publication Date
ECSP14026022A true ECSP14026022A (en) 2015-11-30

Family

ID=56116629

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201426022A ECSP14026022A (en) 2012-04-25 2014-11-07 NITROGENATED HETEROCYCLIC COMPOUND

Country Status (2)

Country Link
EC (1) ECSP14026022A (en)
MA (1) MA37556B1 (en)

Also Published As

Publication number Publication date
MA37556A1 (en) 2016-04-29
MA37556B1 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
CR20140537A (en) NITROGEN HETEROCYCLIC COMPOUND
AR110381A2 (en) BIUTYL INHIBITORS OF TIROSINA CINASA DE BRUTON
CR20130024A (en) FUSED HETEROCYCLIC COMPOUNDS
GT201600086A (en) PIRROLO [12-F] [1,2,4] USEFUL TRIAZINS TO TREAT INFECTIONS BY THE RESPIRATORY SYNCTIAL VIRUS
TR201901886T4 (en) DNA-PK inhibitors.
UY35821A (en) HETEROCYCLIC COMPOUND
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
CO6592104A2 (en) Heterocyclic compound
EA201692526A1 (en) SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS
UY37018A (en) PAD4 BICYCLIC INHIBITORS
JO3316B1 (en) 3,4-dihydroisoquinolin-2(1h)-yl compounds
EA201201374A1 (en) TREATMENT ATAXICS-TELEAGGYSTATICS
BR112014028042A2 (en) nampt inhibitors
GT201500247A (en) IMIDAZOPIRIDAZINAS REPLACED
MX2016003823A (en) A selective inhibitor of phosphatidylinositol 3-kinase-gamma.
EA201891347A1 (en) Aza-benzimidazole inhibitors PAD4
MX370253B (en) Compositions of jasmonate compounds and methods of use.
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
ECSP14011792A (en) IAP INHIBITORS
MX2018008307A (en) Ascochlorin derivative and use thereof as ampk activator.
BR112014030992A2 (en) compositions comprising calcogenides and related methods
BR112017002586A2 (en) tetrahydropyrrol [3,4-d] [1,3] thiazine derivative as a bace inhibitor
ECSP14026022A (en) NITROGENATED HETEROCYCLIC COMPOUND
EA201501177A1 (en) PHARMACEUTICAL COMPOSITIONS
MX2015012381A (en) Fungal immunogens and related materials and methods.